The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Ordonez Kathy since year 2005.
The trader's CIK number is 1222643.
At the time of the last reporting, Ordonez Kathy was the CEO and Director of Pacific Biosciences Of California, Inc. .
(stock ticker symbol PACB).
See this page for all insider trading activities at Pacific Biosciences Of California, Inc. .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2019-02-19 | PACB | Pacific Biosciences Of California, Inc. | Sale | 6,933 | 7.17 | 49,695 |
| 2018-11-27 | PACB | Pacific Biosciences Of California, Inc. | Option Ex | 25,000 | 2.90 | 72,500 |
| 2018-11-27 | PACB | Pacific Biosciences Of California, Inc. | Sale | 25,000 | 7.54 | 188,500 |
| 2009-02-25 | CRA | Celera Corp | Buy | 6,757 | 7.40 | 49,981 |
| 2007-02-07 | ABI/CRA | Applera Corp | Option Ex | 3,360 | 15.54 | 52,214 |
| 2007-02-07 | ABI/CRA | Applera Corp | Sale | 2,518 | 33.28 | 83,804 |
| 2007-02-07 | ABI/CRA | Applera Corp | Sale | 842 | 33.06 | 27,838 |
| 2007-02-06 | ABI/CRA | Applera Corp | Option Ex | 3,360 | 15.54 | 52,214 |
| 2007-02-06 | ABI/CRA | Applera Corp | Sale | 2,241 | 33.24 | 74,499 |
| 2007-02-06 | ABI/CRA | Applera Corp | Sale | 1,119 | 32.99 | 36,920 |
| 2007-02-05 | ABI/CRA | Applera Corp | Option Ex | 3,360 | 15.54 | 52,214 |
| 2007-02-05 | ABI/CRA | Applera Corp | Sale | 3,009 | 33.62 | 101,162 |
| 2007-02-05 | ABI/CRA | Applera Corp | Sale | 351 | 33.41 | 11,726 |
| 2007-02-02 | ABI/CRA | Applera Corp | Option Ex | 3,360 | 15.54 | 52,214 |
| 2007-02-02 | ABI/CRA | Applera Corp | Sale | 1,124 | 34.17 | 38,409 |
| 2007-02-02 | ABI/CRA | Applera Corp | Sale | 2,236 | 33.78 | 75,538 |
| 2007-02-01 | ABI/CRA | Applera Corp | Option Ex | 3,360 | 15.54 | 52,214 |
| 2007-02-01 | ABI/CRA | Applera Corp | Sale | 1,963 | 34.57 | 67,853 |
| 2007-02-01 | ABI/CRA | Applera Corp | Sale | 1,397 | 34.29 | 47,908 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ordonez Kathy (CEO and Director of Pacific Biosciences Of California, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.